Immunic Inc. (IMUX) Misses Q4 EPS by 303c

Immunic Inc. (NASDAQ: IMUX) reported Q4 EPS of ($3.78), $3.03 worse than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch
• BeyondSpring Inc. (BYSI) Reports Q2 Loss of $0.02